+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Heart Failure with Preserved Ejection Fraction, An Issue of Cardiology Clinics. The Clinics: Internal Medicine Volume 40-4

  • Book

  • October 2022
  • Elsevier Health Science
  • ID: 5671534
In this issue of Cardiology Clinics, guest editors Drs. Scott Hummel and Matthew Konerman bring their considerable expertise to the topic of Heart Failure with Preserved Ejection Fraction. Top experts in the field cover key topics such as risk factors for heart failure with preserved ejection fraction (HFpEF); cardiopulmonary stress testing in HFpEF; hemodynamic assessment in HFpEF; the role of multi-modality imaging in the evaluation of HFpEF; and more.
  • Contains 13 relevant, practice-oriented topics including pharmacologic, non-pharmacologic, and device therapy for HFpEF; geriatric domains in patients with HFpEF; pulmonary hypertension in HFpEF; infiltrative, genetic, and other non-standard causes of HFpEF; echocardiography in HFpEF; and more.�

  • Provides in-depth clinical reviews on heart failure with preserved ejection fraction, offering actionable insights for clinical practice.�

  • Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.�

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Table of Contents

Epidemiology, Diagnosis, Pathophysiology, and Initial Approach to Heart Failure with Preserved Ejection Fraction
Key Phenotypes of Heart Failure with Preserved Ejection Fraction: Pathophysiologic Mechanisms and Potential Treatment Strategies
Approach to Echocardiography in Heart Failure with Preserved Ejection Fraction
The Role of Multimodality Imaging in the Evaluation of Heart Failure with Preserved Ejection Fraction
Hemodynamic Assessment in Heart Failure with Preserved Ejection Fraction
Pharmacologic Therapy for Heart Failure with Preserved Ejection Fraction
Nonpharmacological Strategies in Heart Failure with Preserved Ejection Fraction
Device Therapy for Heart Failure with Preserved Ejection Fraction
Geriatric Domains in Patients with Heart Failure with Preserved Ejection Fraction
Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction
Transthyretin Cardiac Amyloidosis: An Evolution in Diagnosis and Management of an "Old� Disease

Authors

Scott L. Hummel Associate Professor, Advanced Heart Failure and Transplant Cardiology, University of Michigan. Matthew C. Konerman Assistant Professor, Advanced Heart Failure and Transplant Cardiology, University of Michigan.